Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients.
about
Fasting cycles potentiate the efficacy of gemcitabine treatment in in vitro and in vivo pancreatic cancer models.Enhancing Drug Efficacy and Therapeutic Index through Cheminformatics-Based Selection of Small Molecule Binary Weapons That Improve Transporter-Mediated Targeting: A Cytotoxicity System Based on Gemcitabine.High expression of the human equilibrative nucleoside transporter 1 gene predicts a good response to decitabine in patients with myelodysplastic syndrome.Development of a metabolites risk score for one-year mortality risk prediction in pancreatic adenocarcinoma patients.Stratification of ALS patients' survival: a population-based study.
P2860
Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Modeling interactions between ...... uctal adenocarcinoma patients.
@ast
Modeling interactions between ...... uctal adenocarcinoma patients.
@en
Modeling interactions between ...... uctal adenocarcinoma patients.
@nl
type
label
Modeling interactions between ...... uctal adenocarcinoma patients.
@ast
Modeling interactions between ...... uctal adenocarcinoma patients.
@en
Modeling interactions between ...... uctal adenocarcinoma patients.
@nl
prefLabel
Modeling interactions between ...... uctal adenocarcinoma patients.
@ast
Modeling interactions between ...... uctal adenocarcinoma patients.
@en
Modeling interactions between ...... uctal adenocarcinoma patients.
@nl
P2093
P2860
P50
P1476
Modeling interactions between ...... ductal adenocarcinoma patients
@en
P2093
Fabio Pellegrini
Francesca Paola Burbaci
Lucia Lombardi
P2860
P2888
P356
10.1186/S12967-014-0248-4
P50
P577
2014-09-10T00:00:00Z